It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn
At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.
Latest News
Dr Martin Main Guest Editor of SLAS Discovery Special February Issue: Advances in Cellular Target Engagement and Target Deconvolution
The February special issue of SLAS Discovery, ‘Advances in Cellular Target Engagement and Target Deconvolution,’ features 11 articles focused on multiple aspects and technologies of
Catapult Network welcomes UK Government’s announcement of support for science, research and innovation
In response to the UK Government’s announcement on investment in science, research and innovation in the UK, and the upcoming Place Strategy for UK research
Medicines Discovery Catapult, use MY data and Incisive Health publish ‘Issue with Tissue’ report
Today (22nd January 2020) Medicines Discovery Catapult, alongside Incisive Health and use MY data published ‘The Issue with Tissue’, a report that brings together key